SCHEMBL1308955

SCHEMBL1308955

COC(=O)CCCCC=C(COc1cccc2ccccc12)C(=O)NCCN(C(C)C)C(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 2/20 0.41
▸ ALDH1A1 P00352 3/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ CNR1 P21554 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ TSHR P16473 1/20 0.39
▸ KMT2A Q03164 1/20 0.38
▸ OGG1 O15527 1/20 0.38
▸ HTR1B P28222 3/20 0.37
▸ NR2E1 Q9Y466 3/20 0.37
▸ ABCB1 P08183 3/20 0.36
▸ BTN3A1 O00481 1/20 0.36
▸ CYP2D6 P10635 3/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ ADRB2 P07550 2/20 0.35
▸ ADRB1 P08588 2/20 0.35
▸ ADRB3 P13945 2/20 0.35
▸ HTR2A P28223 2/20 0.35
▸ HTR2C P28335 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1308954 1.00 CNR2 (0.41) CNR2ALDH1A1KDM4EHPGDCNR1
SCHEMBL1307399 0.92 KDM4E (0.46) CNR2ALDH1A1KDM4EHPGDTDP1
SCHEMBL1307404 0.92 KDM4E (0.46) CNR2ALDH1A1KDM4EHPGDTDP1
SCHEMBL29488467 0.90 KDM4E (0.39) ALDH1A1KDM4EHPGDTDP1TSHR
SCHEMBL1306605 0.90 KDM4E (0.39) ALDH1A1KDM4EHPGDTDP1TSHR
SCHEMBL1306601 0.90 KDM4E (0.39) ALDH1A1KDM4EHPGDTDP1TSHR
SCHEMBL22403025 0.88 HTR1B (0.45) CNR2ALDH1A1KDM4EHPGDCNR1
SCHEMBL1306561 0.86 CNR2 (0.47) CNR2ALDH1A1KDM4EHPGDCNR1
SCHEMBL1306558 0.86 CNR2 (0.47) CNR2ALDH1A1KDM4EHPGDCNR1
SCHEMBL1308956 0.86 ALDH1A1 (0.40) ALDH1A1KDM4EHPGDTDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8053435-B2 Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2011-11-08 — — US disclosed
Send feedback